Literature DB >> 16952302

Routine coronary angiography in diabetic nephropathy patients before transplantation.

B J Witczak1, A Hartmann, T Jenssen, A Foss, K Endresen.   

Abstract

We evaluated the incidence of significant coronary artery stenoses (CAS), angina pectoris (AP), revascularization and associated risk factors in 155 consecutive diabetic nephropathy transplant candidates. Kidney and kidney-pancreas transplant candidates with diabetes for more than 10 years and/or retinopathy and/or biopsy verified diabetic nephropathy were included. The inclusion period was 1999-2004. Seventy-two percent of patients were male. Sixty-one percent had type 1 diabetes and 39% had type 2 diabetes and mean age was 46 years (+/-10) and 58 years (+/-11), respectively. History of heart disease was present in 34% of patients, 34% had cerebro-vascular and/or peripheral atherosclerotic disease, and 51% had neither. Fifty-five percent had a smoking history and 46% were on dialysis. Significant CAS was found in 45% of patients, of whom 17% had AP. No patients below 35 years of age had significant CAS (n = 11, p = 0.001). Revascularization was performed in 57% of patients with significant CAS. The only risk factor for significant CAS in multiple logistic regression was age (p = 0.046). Approximately half of the patients had significant CAS, and half of these underwent revascularization. Most patients with CAS did not have symptoms of myocardial ischemia. The data justify screening diabetic nephropathy transplant candidates with coronary angiography before transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16952302     DOI: 10.1111/j.1600-6143.2006.01491.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

Review 1.  Cardiac testing for coronary artery disease in potential kidney transplant recipients.

Authors:  Louis W Wang; Magid A Fahim; Andrew Hayen; Ruth L Mitchell; Laura Baines; Stephen Lord; Jonathan C Craig; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation.

Authors:  Jørn P Lindahl; Anders Hartmann; Svend Aakhus; Knut Endresen; Karsten Midtvedt; Hallvard Holdaas; Torbjørn Leivestad; Rune Horneland; Ole Øyen; Trond Jenssen
Journal:  Diabetologia       Date:  2015-12-28       Impact factor: 10.122

3.  Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease.

Authors:  J P Lindahl; A Hartmann; R Horneland; H Holdaas; A V Reisæter; K Midtvedt; T Leivestad; O Oyen; T Jenssen
Journal:  Diabetologia       Date:  2013-04-03       Impact factor: 10.122

4.  Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country.

Authors:  Vivek B Kute; Suraj M Godara; Pankaj R Shah; Siddharth H Jain; D P Engineer; Himanshu V Patel; Manoj R Gumber; Bipin C Munjappa; V V Sainaresh; Aruna V Vanikar; Pranjal R Modi; Veena R Shah; Hargovind L Trivedi
Journal:  Int Urol Nephrol       Date:  2011-07-30       Impact factor: 2.370

5.  Outcome of renal transplantation in patients with diabetic nephropathy -- a single-center experience.

Authors:  Vivek B Kute; Aruna V Vanikar; Hargovind L Trivedi; Pankaj R Shah; Kamal R Goplani; Manoj R Gumber; Himanshu V Patel; Suraj M Godara; Pranjal R Modi; Veena R Shah
Journal:  Int Urol Nephrol       Date:  2010-11-24       Impact factor: 2.370

6.  A new risk score model to predict the presence of significant coronary artery disease in renal transplant candidates.

Authors:  Luís Henrique Wolff Gowdak; Flávio Jota de Paula; Luiz Antônio Machado César; Luiz Aparecido Bortolotto; José Jayme Galvão de Lima
Journal:  Transplant Res       Date:  2013-11-01

7.  Pre-operative ankle-brachial index for cardiovascular risk assessment in simultaneous pancreas-kidney transplant recipients: a simple and elegant strategy!

Authors:  Hans-Michael Hau; Nora Jahn; Max Brunotte; Tristan Wagner; Sebastian Rademacher; Daniela Branzan; Elisabeth Sucher; Daniel Seehofer; Robert Sucher
Journal:  BMC Surg       Date:  2021-03-22       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.